» Articles » PMID: 32544504

Vitexin Ameliorates Chronic Stress Plub High Fat Diet-induced Nonalcoholic Fatty Liver Disease by Inhibiting Inflammation

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2020 Jun 17
PMID 32544504
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Evidences showed that chronic stress (CS) can aggravate the situation of nonalcoholic fatty liver disease (NAFLD). Vitexin is one of the major components in hawthorn, which is widely used to reduce blood lipid. This study was aimed to explore the therapeutic effects and potential mechanisms of vitexin on chronic stress mice with high-fat diet (CSHFD). The results showed that 5-week vitexin administration (40 mg/kg, i.g.) could obviously reduce hepatic fat deposition, alleviate lipid metabolism, and inhibit liver inflammation in CSHFD mice. In addition, vitexin significantly reduced hepatic macrophage infiltration, obviously down-regulated the mRNA and protein expressions of hepatic SREBP-1c, FAS, ACC. Moreover, we also found that vitexin treatment could significantly inhibit the expressions of TLR4/NF-κB signaling in CSHFD mice. This results suggested that vitexin could ameliorate chronic stress combined with high-fat diet induced NAFLD, and its mechanisms is closely related to inhibit TLR4/NF-κB signaling and reduce fatty acid synthesis proteins.

Citing Articles

Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease.

Liu Y, Fan Y, Liu J, Liu X, Li X, Hu J Front Pharmacol. 2024; 15:1499602.

PMID: 39605910 PMC: 11598537. DOI: 10.3389/fphar.2024.1499602.


Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification.

Li H, Niu L, Wang M, Liu C, Wang Y, Su Y Heliyon. 2024; 10(15):e35491.

PMID: 39170438 PMC: 11336705. DOI: 10.1016/j.heliyon.2024.e35491.


Traditional Chinese medicines and natural products targeting immune cells in the treatment of metabolic-related fatty liver disease.

Li Z, Ouyang H, Zhu J Front Pharmacol. 2023; 14:1195146.

PMID: 37361209 PMC: 10289001. DOI: 10.3389/fphar.2023.1195146.


Isolation and Quantification of the Hepatoprotective Flavonoids From (Willd.) R. J. Wang With Bio-Enzymatic Method Against NAFLD by UPLC-MS/MS.

Qin Y, Zhao B, Deng H, Zhang M, Qiao Y, Liu Q Front Pharmacol. 2022; 13:890148.

PMID: 35770080 PMC: 9234865. DOI: 10.3389/fphar.2022.890148.


Anti-Inflammatory Effects of Phytochemical Components of .

Ong W, Herr D, Sun G, Lin T Molecules. 2022; 27(11).

PMID: 35684542 PMC: 9182488. DOI: 10.3390/molecules27113607.